29
Participants
Start Date
November 4, 2019
Primary Completion Date
February 17, 2022
Study Completion Date
February 17, 2022
Diabetic
It is a hypercaloric and hyperproteic dietary supplement formulated to contribute to control the glycemia with: a specific mix of carbohydrate with a low GI, fiber, EVOO and EPA\&DHA
Control
It is a hypercaloric and hyperproteic dietary supplement formulated without the ingredients to contribute in the glycemia control
José M. García Almeida, Málaga
Collaborators (1)
Adventia Pharma
INDUSTRY
Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud
OTHER